Stop Guessing. Know Exactly What Your Technical File is Missing for Korea.
A simple translation of your CE MDR or FDA 510(k) dossier will not survive a South Korean technical file review. Identify and close the critical data gaps before submission to prevent months of regulatory delays and costly re-testing.
The "Translate and Submit" trap leads to massive delays.
Many foreign manufacturers assume that if their medical device is approved in Europe or the US, the Korean Authorities will simply accept their existing test reports. This is a costly misconception. The MFDS mandates the Korean Technical Documentation format and applies strict, localized interpretations of electrical safety, biocompatibility, physical and chemical properties, cybersecurity, and software validation standards. Submitting an unoptimized file guarantees a severe deficiency letter, stopping the review clock and delaying your commercial launch by 6 to 9 months. Pre-emptive defense against deficiency letters. We audit your existing Design History File (DHF) or Technical File through the critical lens of a reviewer. Our experts cross-reference your data line-by-line against current South Korean medical device regulations to ensure absolute compliance.
STED Conversion Readiness
Assessing how seamlessly your existing data can be mapped to the mandatory Korean Technical Documentation format.
Test Report Validation
Evaluating your testing data (EMC, Safety, Biocompatibility, cybersecurity) to determine what the authority will accept and what must be re-tested.
Clinical & Performance Scrutiny
Verifying if your current clinical evaluation and performance bench data meet the specific efficacy thresholds required for Korean patients.
The Gap Analysis & Action Plan
You will receive a definitive, engineering-level report outlining exactly what is missing and how to fix it before you officially submit your application. What's inside the report: - Line-by-line STED compliance checklist. - Identification of invalid or outdated test reports. - Actionable remediation strategy (e.g., "Conduct EMC re-testing," or "Draft clinical justification memo"). - Cost and timeline estimates for filling the identified data gaps.
Proven Clarity Across Modalities.
AI Diagnostic Software Pathway
Successfully determined the clinical trial exemption strategy for a novel AI device, cutting the launch timeline by 12 months.
Wellness vs. Medical Device
Reclassified an aesthetic light-therapy device, saving the client from rigorous Class II testing requirements.
Class III Implant Classification
Established a definitive predicate device comparison strategy, avoiding a costly De Novo pathway.
Submit with absolute confidence.
When the authority issues a deficiency letter, you typically have limited time to respond. Avoid the panic of scrambling for data or rushing local testing. By identifying the gaps upfront, you control the timeline, optimize your R&D resources, and ensure a smooth, predictable clearance process.
Speak with a Regulatory Consultant TodayFAQ (Frequently Asked Questions)
Common questions about Technical File Gap Analysis